Anticancer Effects of the Chinese Medicine Matrine on Murine Hepatocellular Carcinoma Cells

Abstract

Matrine is a component of the traditional Chinese medical herb Sophora flavescens Ait, which is widely used to treat diseases such as viral hepatitis, cardiac arrhythmia and skin inflammations. As indicated by previous reports, the molecular mechanism of matrine’s anti-cancer effect has been poorly clarified. In this study, we used both in vitro and in vivo models to investigate matrine’s antitumor effect and its possible molecular mechanisms. Murine hepatocellular carcinoma H22 cells were cultured in the presence of matrine at various concentrations (0.2 - 2.0 mg/mL). A dose-dependent antiproliferation effect was observed. The 50 % inhibitory concentration (IC₅₀) was 0.6 mg/mL. Antiproliferation effects of matrine were associated with an increase in cells arrested in the G₁ phase of the cell cycle. Morphological changes, flow cytometric analysis and expression of the proapototic protein Bax indicated that this anticancer effect was mediated via apoptosis. In vivo antitumor efficacy was evaluated following s. c. inoculation of H22 cells in BALB/c mice. Matrine administrated i. p. resulted in strong in vivo anticancer activity. Our results showed that seven doses of matrine at 50 mg/kg/dose inhibited 60.7 % of tumor growth. Transmission electron microscope (TEM) analysis and histoimmunochemical staining for Bcl-2 and Bax proteins also indicated induction of apoptosis in tumor tissues by matrine. Taken together, our results demonstrate that matrine possesses strong antitumor activities in vitro and in vivo. Inhibition of cell proliferation and induction of apoptosis are the likely mechanisms responsible for matrine’s antitumor activities.

Sophora flavescens - Leguminosae - matrine - anticancer activity - apoptosis - murine hepatocellular carcinoma

References

• 1 Xiao P G. Xinbian Zhongyaozhi. Beijing; Chemistry Industrial Publishing Company 2002: 555-61
• 2 Atta-Ur-Rahman A, Choudhary M I, Parvez K. Quinolizidine alkaloids from Sophora alopecuroides.  J Nat Prod. 2000;  63 190-2
• 3 Zhang M J, Huang J. Recent research progress of anti-tumor mechnism matrine.  Zhongguo Zhong Yao Za Zhi. 2004;  29 115-8
• 4 Zhang Y, Liu X S, Liu B Z, He Y J. Differentiation and apoptosis in K562 erythroleukemia cells induced by matrine.  Natural Med. 1998;  52 295-8
• 5 Zhang L P, Jiang J K, Tam J W, Zhang Y, Liu X S, Xu X R. Effects of matrine on proliferation and differentiation in K562 cells.  Leukoc Res. 2001;  25 793-80
• 6 Zhang Y Q, Huang G S, Wang Z, Guo T, Zhang Y Z. Effects of matrine on the relative molecules expression of proliferation and apoptosis in K562 cell.  Acta Acad Med Sin. 2001;  23 333-6
• 7 Wang Y, Peng C, Zhang G. Study on invasion and metastasis related factors in differentiation of SMMC-7721 cells induced by matrine.  Zhong Yao Cai. 2003;  26 566-9
• 8 Yang J J, Gao S M, Chen H. Apoptosis of multiple myeloma RPMI 8226 cell line induced by matrine.  Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007;  15 515-8
• 9 Luo C, Zhu Y, Jiang T, Lu X, Zhang W, Jing Q. et al . Matrine induced gastric cancer MKN45 cells apoptosis via increasing pro-apoptotic molecules of Bcl-2 family.  Toxicology. 2007;  229 245-52
• 10 Dai Z J, Gao J, Wu W Y, Wang X J, Li Z F, Kang H F. et al . Effect of matrine injections on invasion and metastasis of gastric carcinoma SGC-7901 cells in vitro.  Zhong Yao Cai. 2007;  30 815-9
• 11 Zhang L, Wang T, Wen X, Wei Y, Peng X, Li H. et al . Effect of matrine on HeLa cell adhesion and migration.  Eur J Pharmacol. 2007;  563 69-76
• 12 Liu J, Zhu M, Shi R. Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trial.  Am J Chin Med. 2003;  31 337-54
• 13 Li C Q, Zhu Y T, Zhang F X, Fu L C, Li X H. Anti-HBV effect of liposome-encapsulated matrine in vitro and in vivo.  World J Gastroenterol. 2005;  11 426-8
• 14 Long Y, Lin X Y, Zeng K. Efficacy of intramuscular matrine in the treatment of chronic hepatitis B.  Hepatobiliary Pancreat Dis Int. 2004;  3 69-72
• 15 Zhang J P, Zhang M, Zhou J P. Antifibrotic effects of matrine on in vitro an in vivo models of livier fibrosis in rats.  Acta Pharmacol Sin. 2001;  22 183-6
• 16 Liu M, Liu X Y, Cheng J F. Advance in the pharmacological research on matrine.  Zhongguo Zhong Yao Za Zhi. 2003;  28 801-4
• 17 Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.  Immunol Methods. 1983;  65 55-63
• 18 Hale A J, Smith C A, Sutherland L C. Apoptosis: molecular regulation of cell death.  Eur J Biochem. 1996;  236 1-26
• 19 Adams J M. Ways of dying: multiple pathways to apoptosis.  Gene Dev. 2003;  17 2481-95
• 20 Kluck R M, Green D R, Newmeyer D D. The release of cytochrome c from mitochomdria: a primary site for Bcl-2 regulation of apoptosis.  Science. 1997;  275 1132-6
• 21 Adams J M, Cory S. The Bcl-2 protein family: arbiters of cell survival.  Science. 1998;  281 1322-6
• 22 Reed J C. Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities.  Cell Death Differ. 2006;  13 1378-86
• 23 Adams J M, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy.  Oncogene. 2007;  26 324-37
• 24 Kaufman S H, Earnshaw W C. Induction of apoptosis by cancer chemotherapy.  Exp Cell Res. 2000;  256 42-9
• 25 Liu X S, Jiang J K. Molecular mechanism of matrine induced-apoptosis in leukemia K562 cells.  Am J Chin Med. 2006;  34 095-103
• 26 Kobayashi T, Sawa H, Morikawa J, Ueno S, Katayama N. Bax-induction alone is sufficient to activate apoptosis cascade in wild-type Bax-bearing K562 cells, and the initiation of apoptosis requires simultaneous caspase activation.  Int J Oncol. 2002;  20 723-8